The utility of prostate-specific antigen in the management of advanced prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The utility of prostate-specific antigen in the management of advanced prostate cancer

Published:2013-07-04 Issue:5 Volume:112 Page:548-560
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Crawford E. David¹,Bennett Charles L.²,Andriole Gerald L.³,Garnick Marc B.⁴,Petrylak Daniel P.⁵

Affiliation:

1. University of Colorado School of Medicine; Aurora CO USA

2. South Carolina School of Pharmacy; Columbia SC USA

3. Washington University School of Medicine; St Louis MO USA

4. Harvard Medical School; Boston MA USA

5. Yale University School of Medicine; New Haven CT USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12061/fullpdf

Reference91 articles.

1. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker;Hernandez;Cancer,2004

2. Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate;Ablin;Exp Med Surg,1969

3. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms;Nadji;Cancer,1981

4. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991

5. Screening for prostate cancer: a review of the evidence for the u.s. Preventive services task force;Chou;Ann Intern Med,2011

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer;European Urology Oncology;2023-12

2. Ultra-High Prostate-Specific Antigen Level: A Potential Very-High-Risk Factor for Localized High-Risk Prostate Cancer;Cancers;2023-11-29

3. Tailored pretreatment of serum samples and biomarker extraction afforded by ionic liquids as constituents of aqueous biphasic systems;Separation and Purification Technology;2023-10

4. Comprehensive analysis the diagnosis, malignant progression and immune infiltrate of ANXA6 in prostate cancer;Genes & Genomics;2023-06-13

5. Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics;Cancer Research;2023-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3